ethoglucid has been researched along with Lymphoma, Non-Hodgkin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BHARDWAJ, BV; CLIFFORD, P; WHITTAKER, LR | 1 |
| Abels, J; Hagemeyer, A; Kurth, KH; Sonneveld, P | 1 |
| Bagley, CM; Canellos, GP; Devita, VT; Gallelli, JF; Young, RC | 1 |
1 trial(s) available for ethoglucid and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Clinical trials with 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) given intravenously.
Topics: Antineoplastic Agents; Blood Platelets; Bone Marrow; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Leukocytes; Lymphoma, Non-Hodgkin; Male; Nitrogen Mustard Compounds; Time Factors; Treatment Outcome | 1972 |
2 other study(ies) available for ethoglucid and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.
Topics: Adenocarcinoma; Antineoplastic Agents; Aorta; Aorta, Abdominal; Busulfan; Carcinoma; Carcinoma, Squamous Cell; Cerebrovascular Disorders; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy; Ethoglucid; Heparin; Humans; Hypothermia; Hypothermia, Induced; Kenya; Lymphoma, Non-Hodgkin; Mechlorethamine; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms; Palliative Care; Prognosis; Pulmonary Embolism; Sarcoma; Tourniquets; Toxicology | 1965 |
Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma.
Topics: Aged; Antineoplastic Agents; Doxorubicin; Ethoglucid; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Mitomycins; Urinary Bladder Neoplasms | 1990 |